John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Precigen
PGEN
$2.61B
| $644K | ﹤0.01% |
63,133
+21,500
| +52% | +$139K |
|
|
FINV
2327
FinVolution Group
FINV
$1.03B
| $642K | ﹤0.01% |
+240,493
| New | +$513K |
|
2328
CALL
Autodesk
ADSK
$53B
| $641K | ﹤0.01% |
2,100
-15,900
| -88% | -$4.19M |
|
|
CSLT
2329
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $641K | ﹤0.01% |
493,081
+31,145
| +7% | +$35K |
|
2330
Vale
VALE
$65.2B
| $640K | ﹤0.01% |
+38,190
| New | +$509K |
|
2331
CALL
LiveRamp
RAMP
$2.29B
| $637K | ﹤0.01% |
+8,700
| New | +$555K |
|
2332
State Street Industrial Select Sector SPDR ETF
XLI
$33.1B
| $637K | ﹤0.01% |
+7,195
| New | +$606K |
|
2333
PUT
Tesla
TSLA
$1.38T
| $635K | ﹤0.01% |
2,700
-58,500
| -96% | -$9.98M |
|
2334
Titan International
TWI
$464M
| $634K | ﹤0.01% |
130,413
+110,795
| +565% | +$455K |
|
2335
Vanda Pharmaceuticals
VNDA
$329M
| $634K | ﹤0.01% |
+48,257
| New | +$581K |
|
2336
First Citizens BancShares
FCNCA
$24.4B
| $632K | ﹤0.01% |
+1,100
| New | +$555K |
|
2337
Manitowoc
MTW
$702M
| $630K | ﹤0.01% |
+47,359
| New | +$505K |
|
|
UBA
2338
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $627K | ﹤0.01% |
44,358
-136,150
| -75% | -$1.62M |
|
2339
Tencent Music
TME
$14.3B
| $626K | ﹤0.01% |
+32,553
| New | +$529K |
|
2340
CALL
Union Pacific
UNP
$184B
| $625K | ﹤0.01% |
+3,000
| New | +$599K |
|
2341
Xeris Biopharma Holdings
XERS
$1.59B
| $625K | ﹤0.01% |
+127,094
| New | +$636K |
|
2342
CALL
Diamondback Energy
FANG
$56B
| $624K | ﹤0.01% |
12,900
-93,000
| -88% | -$3.44M |
|
|
PDS
2343
Precision Drilling
PDS
$1.12B
| $624K | ﹤0.01% |
37,843
+36,633
| +3,028% | +$606K |
|
|
CTRA
2344
CALL
DELISTED
Coterra Energy
CTRA
| $622K | ﹤0.01% |
38,200
+8,200
| +27% | +$144K |
|
2345
Karyopharm Therapeutics
KPTI
$43.5M
| $622K | ﹤0.01% |
2,681
-83,162
| -97% | -$19.3M |
|
2346
Oceaneering
OII
$4.97B
| $622K | ﹤0.01% |
+78,191
| New | +$456K |
|
|
SAFE
2347
Safehold
SAFE
$1.1B
| $621K | ﹤0.01% |
+8,587
| New | +$559K |
|
|
ARD
2348
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $621K | ﹤0.01% |
+36,098
| New | +$599K |
|
2349
Carriage Services
CSV
$553M
| $619K | ﹤0.01% |
19,769
-6,265
| -24% | -$171K |
|
2350
PUT
Colgate-Palmolive
CL
$72.8B
| $616K | ﹤0.01% |
7,200
+1,100
| +18% | +$91K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.